Corcept Therapeutics (CORT) is down -15.0%, or -$13.26 to $75.11.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept Therapeutics Board Member Resigns, Continues as Consultant
- Corcept Therapeutics management to meet with Truist
- 3 ‘Outperform’ Healthcare Stocks, According to AI Analyst, 9/10/25
- Corcept Therapeutics price target raised to $140 from $137 at Canaccord
- Corcept Therapeutics’ New Drug Application Accepted by FDA